Header Logo

Connection

Stephen Gehlbach to Osteoporosis

This is a "connection" page, showing publications Stephen Gehlbach has written about Osteoporosis.
Connection Strength

1.743
  1. Gehlbach S, Hooven FH, Wyman A, Diez-Perez A, Adachi JD, Luo X, Bushmakin AG, Anderson FA. Patterns of anti-osteoporosis medication use among women at high risk of fracture: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). PLoS One. 2013; 8(12):e82840.
    View in: PubMed
    Score: 0.410
  2. Gehlbach S, Saag KG, Adachi JD, Hooven FH, Flahive J, Boonen S, Chapurlat RD, Compston JE, Cooper C, D?ez-Perez A, Greenspan SL, LaCroix AZ, Netelenbos JC, Pfeilschifter J, Rossini M, Roux C, Sambrook PN, Silverman S, Siris ES, Watts NB, Lindsay R. Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women. J Bone Miner Res. 2012 Mar; 27(3):645-53.
    View in: PubMed
    Score: 0.362
  3. D?ez-P?rez A, Hooven FH, Adachi JD, Adami S, Anderson FA, Boonen S, Chapurlat R, Compston JE, Cooper C, Delmas P, Greenspan SL, Lacroix AZ, Lindsay R, Netelenbos JC, Pfeilschifter J, Roux C, Saag KG, Sambrook P, Silverman S, Siris ES, Watts NB, Nika G, Gehlbach SH. Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone. 2011 Sep; 49(3):493-8.
    View in: PubMed
    Score: 0.343
  4. Gehlbach SH, Avrunin JS, Puleo E. Trends in hospital care for hip fractures. Osteoporos Int. 2007 May; 18(5):585-91.
    View in: PubMed
    Score: 0.252
  5. Guggina P, Flahive J, Hooven FH, Watts NB, Siris ES, Silverman S, Roux C, Pfeilschifter J, Greenspan SL, D?ez-P?rez A, Cooper C, Compston JE, Chapurlat R, Boonen S, Adachi JD, Anderson FA, Gehlbach S. Characteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort. Bone. 2012 Dec; 51(6):975-80.
    View in: PubMed
    Score: 0.094
  6. FitzGerald G, Boonen S, Compston JE, Pfeilschifter J, LaCroix AZ, Hosmer DW, Hooven FH, Gehlbach SH. Differing risk profiles for individual fracture sites: evidence from the Global Longitudinal Study of Osteoporosis in Women (GLOW). J Bone Miner Res. 2012 Sep; 27(9):1907-15.
    View in: PubMed
    Score: 0.094
  7. Adachi JD, Adami S, Gehlbach S, Anderson FA, Boonen S, Chapurlat RD, Compston JE, Cooper C, Delmas P, D?ez-P?rez A, Greenspan SL, Hooven FH, LaCroix AZ, Lindsay R, Netelenbos JC, Wu O, Pfeilschifter J, Roux C, Saag KG, Sambrook PN, Silverman S, Siris ES, Nika G, Watts NB. Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women. Mayo Clin Proc. 2010 Sep; 85(9):806-13.
    View in: PubMed
    Score: 0.081
  8. Saag KG, Gehlbach SH, Curtis JR, Youket TE, Worley K, Lange JL. Trends in prevention of glucocorticoid-induced osteoporosis. J Rheumatol. 2006 Aug; 33(8):1651-7.
    View in: PubMed
    Score: 0.061
  9. Burge R, Puleo E, Gehlbach S, Worley D, Klar J. Inpatient hospital and post-acute care for vertebral fractures in women. Value Health. 2002 Jul-Aug; 5(4):301-11.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.